Evidence mapPaperPMID 42301540Full record

ArticleMolecular and cellular biochemistry2026

Olfactory bulb 6-OHDA neurotoxicity as a model of early cortical dysfunction.

Edson Fiorenza-Neto, Bruna B Gattiboni, Karin Almeida, Luis F Marqueze, Bassam F Mogharbel, Juliana R N de Aguiar, Larissa C Marques, Larissa R Lazarini, Stephanie R S Carvalhal, Angelica Boldt and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Edson Fiorenza-NetoGraduate Program in Health Sciences, School of Medicine and Life Sciences, Pontifical Catholic University of Parana, Curitiba, Brazil.
Bruna B GattiboniGraduate Program in Health Sciences, School of Medicine and Life Sciences, Pontifical Catholic University of Parana, Curitiba, Brazil.
Karin AlmeidaGraduate Program in Health Sciences, School of Medicine and Life Sciences, Pontifical Catholic University of Parana, Curitiba, Brazil.
Luis F MarquezeGraduate Program in Health Sciences, School of Medicine and Life Sciences, Pontifical Catholic University of Parana, Curitiba, Brazil.
Bassam F MogharbelPelé Pequeno Príncipe Research Institute, Child and Adolescent Health Research & Pequeno Príncipe Faculties, Advanced Therapy and Cellular Biotechnology in Regenerative Medicine Department, Curitiba, Brazil.
Juliana R N de AguiarGraduate Program in Health Sciences, School of Medicine and Life Sciences, Pontifical Catholic University of Parana, Curitiba, Brazil.
Larissa C MarquesGraduate Program in Health Sciences, School of Medicine and Life Sciences, Pontifical Catholic University of Parana, Curitiba, Brazil.
Larissa R LazariniGraduate Program in Health Sciences, School of Medicine and Life Sciences, Pontifical Catholic University of Parana, Curitiba, Brazil.
Stephanie R S CarvalhalDepartment of Genetics, Federal University of Parana (UFPR), Curitiba, Brazil.
Angelica BoldtDepartment of Genetics, Federal University of Parana (UFPR), Curitiba, Brazil.
Ricardo C CunhaUniversidade Positivo, Curitiba, Brazil.
Katherine A T CarvalhoPelé Pequeno Príncipe Research Institute, Child and Adolescent Health Research & Pequeno Príncipe Faculties, Advanced Therapy and Cellular Biotechnology in Regenerative Medicine Department, Curitiba, Brazil.
Anand ThirupathiFaculty of Sports Science, Ningbo University, Ningbo, China.
Zsolt RadakResearch Institute of Sport Science, Hungarian University of Sports Science, Budapest, Hungary.
Ricardo A PinhoGraduate Program in Health Sciences, School of Medicine and Life Sciences, Pontifical Catholic University of Parana, Curitiba, Brazil. ricardo.pinho@pucpr.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The olfactory bulb (OB) is one of the earliest brain regions affected in neurodegenerative diseases such as Parkinson's disease (PD). Its high metabolic rate, dopaminergic modulation, and connectivity with the cortical and limbic regions make it particularly vulnerable to early neuroinflammatory and oxidative processes. This study aimed to investigate whether the administration of 6-hydroxydopamine (6-OHDA) into the OB induces behavioral, redox, and inflammatory alterations associated with early cortical disturbances. Male Wistar rats were randomly assigned to the sham or 6-OHDA groups and underwent stereotaxic injection of the vehicle or 6-OHDA into the left OB. Behavioral performance was assessed in the open-field test 12 days after surgery, and cortical tissue was collected for biochemical and molecular analyses. Cytokines (IL-1β, IL-6, TNF-α, IL-10, IFN-γ, and MCP-1) were quantified by Luminex, redox parameters (CAT, GPx, MDA, and protein carbonyls) by spectrophotometry, and neuronal signaling proteins (c-FOS, CREB, and BDNF) by qPCR. Animals with 6-OHDA lesions exhibited decreased latency and increased time spent in the central zone of the open field, indicating altered exploratory behavior. IL-6 levels were significantly elevated, whereas IFN-γ was reduced in the cortex, while IL-1β, TNF-α, MCP-1, and IL-10 remained unchanged. The oxidative stress markers MDA and protein carbonyls were increased, while catalase and glutathione peroxidase activities showed no change. The expression of c-FOS, CREB, and BDNF was not significantly modified. These findings indicate that localized 6-OHDA administration in the OB is sufficient to elicit behavioral, inflammatory, and oxidative alterations in connected cortical regions, which may resemble early non-motor features associated with olfactory dysfunction, without representing a neurodegenerative disease-specific process.

Indexed as

6-HydroxydopamineInflammationOlfactory bulbOxidative stressParkinson’s disease

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.